Who we are
Claremont Amany Institute (CAI) is a non-profit research institute dedicated to advancing cancer genomics, biobanking, and precision oncology, with a primary focus on African populations.
CAI was established to build the scientific, ethical, and data infrastructure required to generate high-quality evidence in areas where it has historically been lacking.
By integrating rigorous governance, trusted biobanking, and collaborative genomics research, the Institute seeks to enable discoveries that improve patient outcomes locally while contributing meaningfully to global cancer science.
Claremont Amany Institute was founded in recognition of two fundamental realities.
First, that African populations remain profoundly underrepresented in cancer genomics research, limiting the relevance and equity of global scientific knowledge.
Second, that durable progress in this space requires more than isolated studies—it requires institutions designed for stewardship, trust, and long-term collaboration.
From its inception, CAI was conceived not as a single project, but as a platform—one capable of housing biobanks, supporting multidisciplinary research, and sustaining partnerships across hospitals, universities, governments, and industry.
Who we are
Establishing and governing high-quality, ethically managed biobanks, with an initial focus on hematologic malignancies.
Enabling genomic analysis, variant interpretation, and translational research through internal and collaborative capabilities.
Working with clinical, academic, and public-sector partners to strengthen local research ecosystems and promote equitable participation in global science.
Our work is guided by the principle that data and biospecimens must be stewarded responsibly, with clear governance, transparent access policies, and respect for the communities from which they originate.
Governance & Stewardship
Claremont Amany Institute is an independent, mission-locked non-profit organization. The Institute operates with a clear separation between scientific stewardship, ethical oversight, and any downstream commercial activity.
Provides fiduciary oversight, safeguards the Institute’s mission, and ensures accountability to ethical and scientific standards.
Comprised of experts across oncology, genomics, data science, ethics, and public health, these committees guide research priorities and standards.
All programs reflect robust consent, privacy, and access controls, aligned with international best practices and local regulatory requirements.
OUR COMMITMENT
Claremont Amany Institute exists to serve as a trusted steward of data, biospecimens, and scientific collaboration. We are committed to: